Cary Street Partners Financial »

Rani Therapeutics Hldgs shares owned by Cary Street Partners Financial

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Cary Street Partners Financial from 13F filings

Historical chart of Cary Street Partners Financial investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Cary Street Partners Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Cary Street Partners Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $14k 11k 1.35

More positions owned by Cary Street Partners Financial

Apple Stock (AAPL)
Vanguard Value Etf Etf (VTV)
Vanguard Growth Etf Etf (VUG)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Fairlead Tactical Sector ETF Etf (TACK)
Tcw Flexible Income Etf Etf (FLXR)
Jpmorgan Equity Premium Income Etf Etf (JEPI)
Ishares Msci Eafe Growth Etf Etf (EFG)
Amazon Stock (AMZN)
Vanguard Small-cap Etf Etf (VB)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Income Etf Etf (JPIE)
Ishares Msci Eafe Value Etf Etf (EFV)
Jpmorgan Active Growth Etf Etf (JGRO)

View all positions for Cary Street Partners Financial

Top funds holding Rani Therapeutics Hldgs

Samsara BioCapital
AWM Investment Company
Vanguard Group
Susquehanna International
Siren
Jane Street
Geode Capital Management
BlackRock
Nan Fung Group Holdings
683 Capital Management
Citadel Advisors
State Street Corporation
Squarepoint Ops
United Services Automobile Association
Goldman Sachs Group

View all funds holding Rani Therapeutics Hldgs